Search the Newsreel

Greenbrook Opens Its Largest Mental Wellness Center Yet in Rockville, Maryland

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., has opened its largest facility to date in Rockville, Maryland. This 7,000-square-foot "National Center of Excellence" will serve as a model for advanced mental health care, focusing on treatment-resistant depression using NeuroStar Advanced Therapy and …

Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Neuronetics Inc (STIM), listing its major shareholders, their proportion of holdings, and the types of shareholders (e.g., private equity, individual investors, hedge funds). It also provides institutional shareholding data over several quarters and shows recent shareholder activity, …

Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Neuronetics Inc (STIM). It states that no dividends have been distributed over the past five years and no data is available regarding specific dividend dates. The page also displays current stock figures for Neuronetics …

Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Neuronetics Inc (STIM), categorizing its income by business segments and geographical regions. The company's main revenue streams are clinic revenue, treatment sessions, and sales of the NeuroStar Advanced Therapy System, with the vast majority of its …

STIM|Neuronetics Inc|Price:1.730|Chg%:-0.150

This article provides an overview of Neuronetics Inc (STIM), detailing its current stock performance, key financial figures, and analyst ratings. It highlights the company's strong growth, high institutional ownership, and a "Buy" rating from multiple analysts with a target price of $4.50. The content …

Neuronetics (STIM) grants 500,000 RSUs to EVP and CFO Naor Nir

Neuronetics, Inc. has granted its EVP, CFO, and Treasurer, Naor Nir, a restricted stock unit (RSU) award of 500,000 shares of common stock. The RSUs, granted on July 23, 2026, will vest in four equal installments starting July 23, 2027, contingent on his continuous …

Neuronetics names Nir Naor as CFO, promotes Anderson to EVP

Neuronetics, Inc. has appointed Nir Naor as its new Chief Financial Officer, effective July 23, leveraging his extensive experience in finance and life sciences, including his previous role as CFO of Axogen. The company also promoted Cory Anderson to Executive Vice President and General …

Fundo imobiliário do Inter compra fatia de galpão logístico por R$ 26 milhões; veja detalhes

Neuronetics appoints Nir Naor as EVP, CFO and Treasurer; W. Andrew Macan to depart

Neuronetics (STIM) has announced the appointment of Nir Naor as Executive Vice President, Chief Financial Officer, and Treasurer, effective on or about July 23, 2026. This comes as W. Andrew Macan will be departing from his role as Executive Vice President, Chief Legal Officer, …

Greenbrook Gets New General Manager; Legal Head to Step Down Aug. 15

Neuronetics (NASDAQ: STIM) has announced several key management changes, including the appointment of Nir Naor as Chief Financial Officer effective July 23, 2026. The company also promoted Cory Anderson to Executive Vice President and General Manager, Greenbrook, effective July 1, 2026, and announced that …

Neuronetics: A High-Stakes Turnaround Play with 143% Upside Potential

Neuronetics (STIM) presents a speculative investment opportunity with a projected 143% upside, driven by new CEO Dan Reuvers' strategic turnaround efforts, including cost reductions and new commercial strategies. Despite a history of financial challenges like deep losses and high leverage, analysts maintain a "Buy" …

Neuronetics, Inc. Announces Management Changes

Neuronetics, Inc. has announced significant management changes. Nir Naor has been appointed as Executive Vice President and Treasurer, effective July 23, 2026, bringing over 20 years of finance and life sciences experience, including a successful tenure as CFO at Axogen, Inc. Concurrently, Andrew Macan, …

BTIG initiates Neuronetics stock with buy rating on mental health platform

BTIG has initiated coverage on Neuronetics Inc. (NASDAQ:STIM) with a Buy rating and a price target of $5.00, suggesting substantial upside from its current price. The company has transitioned into a vertically integrated mental health platform following its acquisition of Greenbrook TMS in December …

STIM Initiated Coverage by BTIG -- Price Target Set at $5.00

BTIG has initiated coverage on Neuronetics (STIM) with a "Buy" rating and a price target of $5.00, signaling a positive outlook for the company. GuruFocus data suggests STIM is undervalued by 17.3% with a GF Value™ of $1.96, and strong insider buying activity of …

Neuronetics Inc. STIM Slides As Weak Margins Pressure Stock

Neuronetics Inc. (STIM) experienced an 8.99% drop in its stock price due to critical clinical trial setbacks and weak margins. Despite solid revenue growth, the company faces significant challenges with negative profitability, high leverage, and negative cash flow, indicating a high-risk trading profile. Analysts …

Neuronetics Inc. Stock Dips As Traders Weigh Losses And Cash Burn

Neuronetics Inc. (NASDAQ: STIM) stock declined by 8.99% due to intensifying concerns over future growth, heavy losses, and negative cash flow, despite solid revenue growth. Analysts maintain a negative outlook, highlighting the company's fragile balance sheet, high leverage, and lack of a clear path …

Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles (NASDAQ:STIM)

Insider Buying: Jorey Chernett Acquires 35,000 Shares of Neuronetics Inc (STIM)

Jorey Chernett, a 10% owner of Neuronetics Inc (STIM), purchased 35,000 shares on July 14, 2026, increasing his total holdings to 10,588,988 shares. This acquisition is part of a trend where Chernett has bought over 3.6 million shares in the past year with no …

Form 4 Neuronetics Inc For: 15 July By Investing.com

This article from Investing.com announces the filing of Form 4 for Neuronetics Inc. on July 15. The brief piece includes the stock symbol STIM and notes a 3.95% increase for the company. It serves as a concise update on a regulatory filing for Neuronetics.

Neuronetics: Jorey Chernett acquires $62,300 common stock

Jorey Chernett, a 10% owner of Neuronetics, Inc. (NASDAQ:STIM), acquired 35,000 shares of common stock for $62,300 on July 14, 2026. This transaction increased his direct holdings to 10,588,988 shares. Despite a recent 15% stock return, InvestingPro analysis indicates the shares are trading above …

OranjeBTC (OBTC3) tem prejuízo de R$ 460 milhões com queda do Bitcoin (BTC) — mas empresa vai às compras mesmo assim

Resultados do 1º tri 2026 da Alupar ficam abaixo do esperado e ações recuam - Investing.com Brasil

Hapvida (HAPV3): JP Morgan avalia que ativos do Sul pressionam resultados e potencial venda reduz 'distrações' da gestão

OranjeBTC (OBTC3) registra prejuízo de R$ 470 milhões no primeiro balanço e lança ADRs nos EUA

Hapvida (HAPV3): resultados do 4T25 pioram e reforçam cautela com a ação

Lucro regulatório da Alupar (ALUP11) sobe +96% no 4º tri

Triunfo registra prejuízo de R$ 322,7 milhões no 4T25, após pressão nas concessões rodoviárias

Alupar registra lucro regulatório de R$ 340 milhões no 4T25, alta de 51%, e reforça desempenho na B3

Ações da Alupar sobem apesar de resultados do 4T de 2025 ficarem abaixo das expectativas - Investing.com Brasil

Here's What's Concerning About Perusahaan Sadur Timah Malaysia (Perstima) Berhad's (KLSE:PERSTIM) Returns On Capital

Patria Renda Urbana (HGRU11) | Elevada previsibilidade de resultados e gestão ativa eficiente

CVC (CVCB3): bancão e fundo de investimento elevam participação para mais de 20%

MXRF11 vale a pena para renda passiva? Quanto o fundo pode pagar no longo prazo

FII do Patria conclui operacão entre shoppings e registra lucro de R$ 40,3 milhões

Análise técnica do Oranjebtc SA Educacao e Investimento (BMFBOVESPA:OBTC3)

MXRF11 vale a pena? O fundo imobiliário mais popular da B3 ainda é um bom investimento